Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study. [electronic resource]
Producer: 20050901Description: 749-55 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Carboplatin -- administration & dosage
- Chemotherapy, Adjuvant
- Confidence Intervals
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Ovarian Neoplasms -- mortality
- Ovariectomy -- methods
- Paclitaxel -- administration & dosage
- Palliative Care
- Probability
- Prognosis
- Quality of Life
- Risk Assessment
- Spain
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.